Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aytu Biopharma Inc (NQ: AYTU )

0.1850 +0.0006 (+0.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,639,904
Open 0.1850
Bid (Size) 0.1870 (8)
Ask (Size) 0.1970 (28)
Prev. Close 0.1844
Today's Range 0.1800 - 0.1923
52wk Range 0.1800 - 2.990
Shares Outstanding 62,432,727
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aytu BioPharma's Return On Capital Employed Insights
According to data from Benzinga Pro, during Q4, Aytu BioPharma's (NASDAQ:AYTU) reported sales totaled $27.45 million. Despite a 66.65% increase in earnings, the company posted a loss of $17.70... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million. 
Via Benzinga

Performance

YTD
-88.06%
-88.06%
1 Month
-16.85%
-16.85%
3 Month
-72.39%
-72.39%
6 Month
-82.55%
-82.55%
1 Year
-93.58%
-93.58%

More News

Read More
Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue
Via ACCESSWIRE
Earnings Scheduled For September 27, 2022
Via Benzinga
Aytu BioPharma's Earnings: A Preview
Via Benzinga
Aytu BioPharma Announces Addition of Fourth Patent License for AR101/Enzastaurin
Via ACCESSWIRE
Aytu BioPharma Announces Issuance of Its First Patent for AR101/Enzastaurin
Via ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Aytu BioPharma to Report Fourth Quarter and Fiscal 2022 Financial Results on September 27, 2022
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Aytu BioPharma to Participate in September 2022 Investor Conferences
Via ACCESSWIRE
Aytu BioPharma Announces Closing of $10.0 Million Registered Public Offering
Via ACCESSWIRE
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Dow Drops Over 100 Points; Verona Pharma Shares Jump
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Aytu BioPharma Announces Pricing of Public Offering
Via ACCESSWIRE
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.